Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04547257Not ApplicableActive Not Recruiting

Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19

Role: collaborator

NCT03027453Completed

Berlin - SPecific Acute Treatment in Ischemic or hAemorrhagic Stroke With Long Term Follow-up

Role: collaborator

NCT04260789Not ApplicableUnknown

Reduction of Pathogen Load From the Blood in Septic Patients With Suspected, Life-threatening Bloodstream Infection

Role: collaborator

NCT01586702Not ApplicableCompleted

Intensified Secondary Prevention Intending a Reduction of Recurrent Events in TIA and Minor Stroke Patients

Role: collaborator

NCT02875431Unknown

Multicentric Registry for the Detection of C5 Palsy After Anterior Cervical Discectomy and Fusion

Role: collaborator

All 5 trials loaded